Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Fresno
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fresno, CA

Studies commonly pay $75 to $4,500 per completed study

166 clinical trials are currently recruiting participants within 30 miles of Fresno. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

166studies recruiting
4+research centers nearby
6condition categories
Live from the NIH registry

Studies recruiting near Fresno right now

Top 25 of 166 recruiting studies, sorted by proximity — each links to its official registry page

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Phase 3 Interventional 5,951 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03959085)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Multiple Myeloma Phase 3 Interventional 893 participants sought
University of California San Francisco — Fresno, California (2.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05020236)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathic Pain Phase 3 Interventional 1,100 participants sought
Neuro-Pain Medical Center — Fresno, California (2.7 mi) · Sponsor: Vertex Pharmaceuticals Incorporated
See eligibility & contact on ClinicalTrials.gov (NCT06628908)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

Muscular Atrophy, Spinal Phase 4 Interventional 28 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT05861999)

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Pulmonary Hypertension, Interstitial Lung Disease N/A Observational 80 participants sought
The Medical Research Group, Inc. — Fresno, California (2.7 mi) · Sponsor: Liquidia Technologies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06129240)

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 130 participants sought
Community Cancer Institute (CCI) — Clovis, California (5.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Parkinson Disease, Parkinson Phase 2 Interventional 150 participants sought
Neuro-Pain Medical Center — Fresno, California (2.7 mi) · Sponsor: Neuron23 Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06680830)

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Malignant Solid Neoplasm N/A Observational 2,062 participants sought
VA Central California Fresno Medical Center — Fresno, California (2.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04871542)

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Mantle Cell Lymphoma, B Cell Lymphoma Phase 3 Interventional 300 participants sought
Ucsf Fresno — Fresno, California (2.7 mi) · Sponsor: BeOne Medicines
See eligibility & contact on ClinicalTrials.gov (NCT06742996)

A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

Malocclusion N/A Interventional 90 participants sought
Costanzo Orthodontics — Fresno, California (2.7 mi) · Sponsor: Dentsply Sirona Implants and Consumables
See eligibility & contact on ClinicalTrials.gov (NCT07290790)

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Wound Heal, Ulcer N/A Interventional 235 participants sought
Limb Preservation Platform — Fresno, California (2.7 mi) · Sponsor: ConvaTec Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06616844)

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Sickle Cell Disease Phase 3 Interventional 192 participants sought
University of California San Francisco- Site Number : 8400040 — Clovis, California (5.8 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06975865)

International Rare Histiocytic Disorders Registry (IRHDR)

Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD) N/A Observational 400 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: The Hospital for Sick Children
See eligibility & contact on ClinicalTrials.gov (NCT02285582)

A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia Phase 3 Interventional 170 participants sought
UCSF FRESNO/Community Cancer Institute /ID# 270874 — Clovis, California (5.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06428019)

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers N/A Interventional 240 participants sought
Limb Preservation Platform Inc — Fresno, California (2.7 mi) · Sponsor: Tides Medical
See eligibility & contact on ClinicalTrials.gov (NCT06681428)

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Metabolic Dysfunction-Associated Steatotic Liver Disease Phase 3 Interventional 4,500 participants sought
Fresno Clinical Research Center — Fresno, California (2.7 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07165028)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular Phase 3 Interventional 750 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT03126916)
Actively enrolling

Studies you may be able to join near Fresno

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Fresno

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Fresno Clinical Research Center

★ 5.0
7102 N Fresno St Ste 101, Fresno, CA 93720
(559) 712-6199
"Very kind and very professional"
— Vivian, 5★

Beacon Clinical Resarch Institute

1111 E Warner Ave, Fresno, CA 93720
(410) 718-2908

Valley Research

★ 5.0
550 E Herndon Ave #101, Fresno, CA 93720
(559) 261-0992
"I just completed a diabetic study with Valley Research. I worked with Lucas Anderson and Rowena Liwag. The knowledge that was shared was immense, we…"
— Betty Benoit, 5★

Clinical Research Center

Fresno, CA 93720
(559) 450-7790

Clinical trials in Fresno: what's recruiting

The Fresno area currently has 166 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fresno, the most active research areas are:

  • Cancer & Oncology11 studies
  • Diabetes & Metabolism3 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Fresno, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fresno

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fresno participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fresno pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fresno?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Fresno safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Fresno?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fresno.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fresno typically complete one or two studies per year.

Paid clinical trials near Fresno

Other metros within reach

Visalia, CA2 Merced, CA27 Modesto, CA106 Bakersfield, CA72 Salinas, CA46 Stockton, CA107 Santa Maria, CA92 San Jose, CA1,134

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Fresno Bladder Issues Due To Spinal Cord Injury in Fresno All conditions

More of CA

Long Beach3,380 Fullerton3,269 Torrance3,260 Anaheim3,212 Garden Grove3,202 Pomona3,169 Glendale2,968 Los Angeles2,945 Huntington Beach2,870 Santa Clarita2,368 Hayward2,274 Fremont2,265

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts